These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 15141093

  • 1. Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets.
    Maedler K, Sergeev P, Ehses JA, Mathe Z, Bosco D, Berney T, Dayer JM, Reinecke M, Halban PA, Donath MY.
    Proc Natl Acad Sci U S A; 2004 May 25; 101(21):8138-43. PubMed ID: 15141093
    [Abstract] [Full Text] [Related]

  • 2. Beta-cells in type 2 diabetes: a loss of function and mass.
    Maedler K, Donath MY.
    Horm Res; 2004 May 25; 62 Suppl 3():67-73. PubMed ID: 15539803
    [Abstract] [Full Text] [Related]

  • 3. Expression of an insulin/interleukin-1 receptor antagonist hybrid gene in insulin-producing cell lines (HIT-T15 and NIT-1) confers resistance against interleukin-1-induced nitric oxide production.
    Welsh N, Bendtzen K, Welsh M.
    J Clin Invest; 1995 Apr 25; 95(4):1717-22. PubMed ID: 7706480
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of IL-1ra gene up-regulates interleukin-1beta converting enzyme (ICE) gene expression: possible mechanism underlying IL-1beta-resistance of cancer cells.
    Sumitomo M, Tachibana M, Murai M, Hayakawa M, Nakamura H, Takayanagi A, Shimizu N.
    Br J Cancer; 1999 Sep 25; 81(2):277-86. PubMed ID: 10496353
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of the IL-1 system components during in vitro myogenesis: implication of IL-1beta in induction of myogenic cell apoptosis.
    Authier FJ, Chazaud B, Plonquet A, Eliezer-Vanerot MC, Poron F, Belec L, Barlovatz-Meimon G, Gherardi RK.
    Cell Death Differ; 1999 Oct 25; 6(10):1012-21. PubMed ID: 10556979
    [Abstract] [Full Text] [Related]

  • 6. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.
    François M, Richette P, Tsagris L, Fitting C, Lemay C, Benallaoua M, Tahiri K, Corvol MT.
    Arthritis Rheum; 2006 Apr 25; 54(4):1233-45. PubMed ID: 16572457
    [Abstract] [Full Text] [Related]

  • 7. Adenoviral overexpression of interleukin-1 receptor antagonist protein increases beta-cell replication in rat pancreatic islets.
    Téllez N, Montolio M, Biarnés M, Castaño E, Soler J, Montanya E.
    Gene Ther; 2005 Jan 25; 12(2):120-8. PubMed ID: 15578044
    [Abstract] [Full Text] [Related]

  • 8. Interleukin (IL)-1beta toxicity to islet beta cells: Efaroxan exerts a complete protection.
    Papaccio G, Graziano A, Valiante S, D'Aquino R, Travali S, Nicoletti F.
    J Cell Physiol; 2005 Apr 25; 203(1):94-102. PubMed ID: 15389634
    [Abstract] [Full Text] [Related]

  • 9. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.
    Arthritis Rheum; 2005 Mar 25; 52(3):759-69. PubMed ID: 15751073
    [Abstract] [Full Text] [Related]

  • 10. FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication.
    Maedler K, Fontana A, Ris F, Sergeev P, Toso C, Oberholzer J, Lehmann R, Bachmann F, Tasinato A, Spinas GA, Halban PA, Donath MY.
    Proc Natl Acad Sci U S A; 2002 Jun 11; 99(12):8236-41. PubMed ID: 12060768
    [Abstract] [Full Text] [Related]

  • 11. Liposome-mediated transfer of IL-1 receptor antagonist gene to dispersed islet cells does not prevent recurrence of disease in syngeneically transplanted NOD mice.
    Saldeen J, Sandler S, Bendtzen K, Welsh N.
    Cytokine; 2000 Apr 11; 12(4):405-8. PubMed ID: 10805224
    [Abstract] [Full Text] [Related]

  • 12. A biphasic role of nuclear transcription factor (NF)-kappaB in the islet beta-cell apoptosis induced by interleukin (IL)-1beta.
    Papaccio G, Graziano A, D'Aquino R, Valiante S, Naro F.
    J Cell Physiol; 2005 Jul 11; 204(1):124-30. PubMed ID: 15622524
    [Abstract] [Full Text] [Related]

  • 13. The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1 beta.
    Watson JM, Lofquist AK, Rinehart CA, Olsen JC, Makarov SS, Kaufman DG, Haskill JS.
    J Immunol; 1995 Nov 01; 155(9):4467-75. PubMed ID: 7594609
    [Abstract] [Full Text] [Related]

  • 14. Direct contact with stimulated T cells induces the expression of IL-1beta and IL-1 receptor antagonist in human monocytes. Involvement of serine/threonine phosphatases in differential regulation.
    Vey E, Dayer JM, Burger D.
    Cytokine; 1997 Jul 01; 9(7):480-7. PubMed ID: 9237810
    [Abstract] [Full Text] [Related]

  • 15. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
    Park YJ, Warnock GL, Ao Z, Safikhan N, Meloche M, Asadi A, Kieffer TJ, Marzban L.
    Diabetes Obes Metab; 2017 May 01; 19(5):682-694. PubMed ID: 28058779
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-15 delays human neutrophil apoptosis by intracellular events and not via extracellular factors: role of Mcl-1 and decreased activity of caspase-3 and caspase-8.
    Bouchard A, Ratthé C, Girard D.
    J Leukoc Biol; 2004 May 01; 75(5):893-900. PubMed ID: 14982947
    [Abstract] [Full Text] [Related]

  • 17. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.
    Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY.
    J Clin Invest; 2002 Sep 01; 110(6):851-60. PubMed ID: 12235117
    [Abstract] [Full Text] [Related]

  • 18. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function.
    Granata R, Settanni F, Gallo D, Trovato L, Biancone L, Cantaluppi V, Nano R, Annunziata M, Campiglia P, Arnoletti E, Ghè C, Volante M, Papotti M, Muccioli G, Ghigo E.
    Diabetes; 2008 Apr 01; 57(4):967-79. PubMed ID: 18162507
    [Abstract] [Full Text] [Related]

  • 19. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
    Molnar C, Garcia-Trevijano ER, Ludwiczek O, Talabot D, Kaser A, Mato JM, Fritsche G, Weiss G, Gabay C, Avila MA, Tilg H.
    Eur Cytokine Netw; 2004 Apr 01; 15(4):303-11. PubMed ID: 15627638
    [Abstract] [Full Text] [Related]

  • 20. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
    Callewaert HI, Gysemans CA, Ladrière L, D'Hertog W, Hagenbrock J, Overbergh L, Eizirik DL, Mathieu C.
    Diabetes; 2007 Aug 01; 56(8):2169-73. PubMed ID: 17473223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.